Bal_2021_Arch.Pharm.(Weinheim)__e2000422

Reference

Title : Synthesis, characterization, crystal structure, alpha-glycosidase, and acetylcholinesterase inhibitory properties of 1,3-disubstituted benzimidazolium salts - Bal_2021_Arch.Pharm.(Weinheim)__e2000422
Author(s) : Bal S , Demirci O , Sen B , Taslimi P , Aktas A , Gok Y , Aygun M , Gulcin I
Ref : Arch Pharm (Weinheim) , :e2000422 , 2021
Abstract :

Chloro-/fluorobenzyl-substituted benzimidazolium salts were synthesized from the reaction of 4-fluorobenzyl/2-chloro-4-fluorobenzyl-substituted benzimidazole and chlorinated aromatic hydrocarbons. They were characterized using various spectroscopic techniques (Fourier-transform infrared and nuclear magnetic resonance) and elemental analysis. In addition, the crystal structures of the complexes 1a -d and 2b were determined by single-crystal X-ray diffraction methods. These compounds were crystallized in the triclinic crystal system with a P-1 space group. The crystal packing of all complexes is dominated by O-H...Cl hydrogen bonds, which link the water molecules and chloride anions, forming a chloride-water tetrameric cluster. These synthesized salts were found to be effective inhibitors for alpha-glycosidase and acetylcholinesterase (AChE), with K(i) values ranging from 45.77+/-6.83 to 102.61+/-11.56 microM for alpha-glycosidase and 0.94+/-0.14 to 10.24+/-1.58 microM for AChE. AChE converts acetylcholine into choline and acetic acid, thus causing the return of a cholinergic neuron to its resting state. Discovering AChE and alpha-glycosidase inhibitors is one of the important ways to develop new drugs for the treatment of Alzheimer's disease and diabetes.

PubMedSearch : Bal_2021_Arch.Pharm.(Weinheim)__e2000422
PubMedID: 33427318

Related information

Citations formats

Bal S, Demirci O, Sen B, Taslimi P, Aktas A, Gok Y, Aygun M, Gulcin I (2021)
Synthesis, characterization, crystal structure, alpha-glycosidase, and acetylcholinesterase inhibitory properties of 1,3-disubstituted benzimidazolium salts
Arch Pharm (Weinheim) :e2000422

Bal S, Demirci O, Sen B, Taslimi P, Aktas A, Gok Y, Aygun M, Gulcin I (2021)
Arch Pharm (Weinheim) :e2000422